Clinical trial
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003398 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00003398 |
|---|---|
| Title | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
| Official title | Evaluation of Allogeneic Marrow Transplants Depleted of T-Cells by CD34+ Selection in Patients Undergoing Transplantation With an Unrelated Matched or 1 Antigen Mismatched Donor or a 1 Antigen Mismatched Related Donor |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | University of Maryland Greenebaum Cancer Center |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, filgrastim, cyclophosphamide, thiotepa, allogeneic bone marrow transplantation, bone marrow ablation with stem cell support, radiation therapy |
| Enrollment | 45 |
| Start date | Sep 1, 1998 |
| Primary completion | May 1, 2000 |
| Completion | May 1, 2000 |
| First posted | Apr 27, 2004 |
| Last update posted | Oct 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: